Table 3. Summary of recent and/or popular total ankle replacements and their outcomes.
Implant | Study | No. of implants | Follow-up (years), median (IQR) | Survivorship | Reoperation rate |
---|---|---|---|---|---|
Agility | Knecht, 2004 (74) | 132 | 9.0 (7.0 to 16) | 89.00% | Not recorded |
Raikin, 2017 (22) | 115 | 9.1 (4.0 to 14) | 78.20% | Not recorded | |
Cadence | Fram, 2022 (75) | 58 | Minimum 2 | 94.80% | 20.70% |
Kim, 2023 (30) | 48 | 2.8 (2.0 to 4.2) | 93.80% | 6.30% | |
HINTEGRA | Yang, 2019 (76) | 210 | 6.4 (2.0 to 13.4) | 91.70% | 9.00% |
Yoon, 2022 (77) | 151 | 11.3 (10 to 17) | 93.50% | 22.50% | |
INBONE I | Adams, 2014 (17) | 194 | 3.7 (2.2 to 5.5) | 89.00% | 25% |
Harston, 2017 (78) | 149 | 5.9 (4.0 to 9.4) | 90.60% | 13.40% | |
INBONE II | Lewis, 2015 (79) | 56 | 2.1 (1.3 to 2.9) | 97.40% | 15.90% |
Gagne, 2022 (20) | 51 | 6.4 (5.0 to 9.0) | 98.00% | 7.80% | |
INFINITY | Saito, 2018 (33) | 64 | 2.0 (1.5 to 3.3) | 95.30% | 17.10% |
Cody, 2019 (80) | 159 | 1.6 (1.0 to 3.1) | 90.00% | Not recorded | |
Salto Talaris | Stewart, 2017 (23) | 106 | 6.8 (5.0 to 9.6) | 95.80% | 19.00% |
Day, 2020 (22) | 85 | 7.1 (5.0 to 12) | 97.60% | 21.20% | |
STAR | Wood, 2003 (81) | 143 | 7.3 (5.0 to 13.0) | 80.30% | Not recorded |
Clough, 2019 (82) | 87 | 15.8 (11.1 to 24.5) | 76.16% | Not recorded | |
Zimmer | Barg, 2018 (83) | 55 | 2.2 (1.9 to 2.6) | 93.00% | 18.20% |
Maccario, 2022 (29) | 86 | 5.4 (5.0 to 7.5) | 97.70% | Not recorded |
IQR, interquartile range.